makers of semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Denmark-based #NovoNordisk, makers of popular

At Set Point Medical Weight Loss Clinic, your safety is our top priority

Whilst fatigue is not listed as a common side effect in the Summary of Product Characteristics, some patients do report feeling tired whilst taking this medication

Abnormal Changes: Extremely heavy bleeding, prolonged periods (lasting more than 7 days), or no period for three or more months without explanation

You can read a more in-depth explanation and analysis of risk from the Cleveland Clinic , but heres the bottom line: Out of an abundance of caution, anyone with a personal or family history making them more susceptible to C cell thyroid cancer (specifically) is advised not to use a GLP-1 medication

Understanding your semaglutide concentration and how it relates to your unit measurements becomes important when considering any dosing modification